Robert Gross
Professor of Medicine (Infectious Diseases)
Attending Physician, Infectious Diseases, Corporal Michael J. Crescenz Veterans Affairs Medical Center
Member, Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine
Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Perelman School of Medicine
Senior Fellow, Leonard Davis Institute, University of Pennsylvania, Perelman School of Medicine
Co-Director, Clinical Core, Penn Center for AIDS Research (CFAR) Perelman School of Medicine
Co-Director, Clinical Assessment Core, Penn Mental Health in AIDS Research Center
Senior Fellow , Center for Public Health Initiatives (CPHI), Perelman School of Medicine
Co-Director , Penn Center for AIDS Research, Perelman School of Medicine
Director, International Core, Penn Center for AIDS Research, International Core
Center for Global Health Scholar, University of Pennsylvania Perelman School of Medicine
Department: Medicine
Contact information
804 Blockley Hall
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania, Perelman School of Medicine
423 Guardian Drive
Philadelphia, PA 19104-6021
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania, Perelman School of Medicine
423 Guardian Drive
Philadelphia, PA 19104-6021
Office: 215-898-2437
Fax: 215-573-5315
Fax: 215-573-5315
Publications
Education:
BA (Italian)
Cornell University , 1986.
MD
Cornell University, 1991.
MSCE (Pharmacoepidemiology)
University of Pennsylvania, 2000.
BA (Italian)
Cornell University , 1986.
MD
Cornell University, 1991.
MSCE (Pharmacoepidemiology)
University of Pennsylvania, 2000.
Links
Search PubMed for articles
Center for Clinical Epidemiology and Biostatistics faculty webpage.
Search PubMed for articles
Center for Clinical Epidemiology and Biostatistics faculty webpage.
Post-Graduate Training
Intern in Medicine, Hospital of the University of Pennsylvania, Perelman School of Medicine, 1991-1992.
Resident in Medicine, University of Pennsylvania, Perelman School of Medicine, 1992-1994.
Fellow in Infectious Diseases, Hospital of the University of Pennsylvania, Perelman School of Medicine, 1995-1998.
Fellow in Pharmacoepidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Perelman School of Medicine, 1996-1999.
Intern in Medicine, Hospital of the University of Pennsylvania, Perelman School of Medicine, 1991-1992.
Resident in Medicine, University of Pennsylvania, Perelman School of Medicine, 1992-1994.
Fellow in Infectious Diseases, Hospital of the University of Pennsylvania, Perelman School of Medicine, 1995-1998.
Fellow in Pharmacoepidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Perelman School of Medicine, 1996-1999.
Certifications
Internal Medicine, American Board of Internal Medicine, 1995.
Infectious Diseases, American Board of Internal Medicine, 1997.
Epidemiology, American College of Epidemiology, 2001.
Infectious Diseases (recertification), American Board of Internal Medicine, 2007.
Infectious Diseases (recertification), American Board of Internal Medicine, 2018.
Permanent linkInternal Medicine, American Board of Internal Medicine, 1995.
Infectious Diseases, American Board of Internal Medicine, 1997.
Epidemiology, American College of Epidemiology, 2001.
Infectious Diseases (recertification), American Board of Internal Medicine, 2007.
Infectious Diseases (recertification), American Board of Internal Medicine, 2018.
Description of Research Expertise
HIV clinical epidemiology; outcomes of HIV treatment; adherence to therapy including development of methods to measure adherenceDescription of Clinical Expertise
HIV; infectious diseasesSelected Publications
Mannathoko N, Mosepele M, Gross R, Smith R, Styczynski A, Cressman L, Richard-Greenblatt M, Glaser L, Alby K, Jaskowiak-Barr A, Sewawa K, Cowden L, Otukile D, Paganotti GM, Mokomane M, Bilker WB, Lautenbach E: Risk Factors for Community Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study. Clinical Infectious Diseases 2023 (in press).Li P, Prajapati G, Geng Z, Ladage VP, Arduino JM, Watson DL, Gross R, Doshi JA.: Antiretroviral Treatment Gaps and Adherence among People With HIV in the U.S. Medicare Program AIDS and Behavior 2023 (in press).
Pickel J, Fiks AG, Karavite D, Maleki P, Beidas RS, Dowshen N, Petsis D, Gross R, Wood S : Provider perspectives on clinical decision support to improve HIV prevention in pediatric primary care: A multiple methods study Implementation Science Communications 2023 (in press).
Golder S, Medaglio D, O’Connor K, Gross R, Hennessy S, Gonzalez Hernandez G: Reasons for Discontinuation or Change of Selective Serotonin Reuptake Inhibitors. JAMA Network Open 2023 (in press).
Motlokwa PK, Tsima BM, Gross R: Prior Treatment For Tuberculosis Associated With Salivary Gland Dysfunction In People With HIV. International Journal of Oral and Dental Health 2023 (in press).
Medaglio D, Bilker WB, Han X, Merlin JS, Plankey M, Martin J, Crane HM, Hojat LS, Bamford L, Schnoll R, Tyndale RF, *Ashare RL, *Gross R (*equal work by authors): Nicotine Metabolite Ratio Decreases after Switching off Efavirenz-based Therapy in People with HIV who Smoke. Clinical Pharmacology and Therapeutics 2023 (in press).
Van Pelt A, Bilker WB, Nkwihorez H, Ghadimi F, Brady KA, Cidav Z, Schriger S, Beidas RS, Gross R, Momplaisir F,: Increasing anti-retroviral therapy adherence and retention in care among adults living with HIV in Philadelphia: A study protocol for a stepped-wedge cluster-randomized type 2 hybrid effectiveness-implementation trial of Managed Problem Solving Plus (MAPS+) delivered by community health workers. BMJ Open 2023 (in press).
Arens Y, Bilker WB, Han X, Plankey M, Ware D, Friedman MR, D’Souza G, Stosor V, Shoptaw S, Schnoll RA, Tyndale RF, Ashare R*, Gross R* *equal contribution by authors: HIV Infection Does Not Explain Higher Nicotine Metabolism in People Living with HIV. JAIDS 2022 (in press).
Tsima BM, Opondo P, Mosepele M, Mautle E, Bilker WB, Gross R: Prevalence of the metabolic syndrome and associated factors among inpatients with severe mental illness in Botswana: a cross-sectional study. BMC Cardiovascular Disorders 2022 (in press).
Avihingsanon A, Hughes MD, Salata R, Godfrey C, McCarthy C, Mugyenyi P, Hogg E, Gross R, Cardoso SW, Bukuru A, Makanga M, Badal-Faesen S, Mave V, Wangari Ndege B, Nerette Fontain S, Samaneka W, Secours R, Van Schalkwyk M, Mngqibisa R, Mohapi L, Valencia J, Sugandhavesa P, Montalban E, Munyanga C, Chagomerana M, Santos BR, Kumarasamy N, Kanyama C, Schooley RT, Mellors JW, Wallis CL, Collier AC, Grinsztejn B for the A5288 Study team: Third-line antiretroviral therapy including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR) is well tolerated and achieves durable virologic suppression over 144+ weeks in resource limited settings: ACTG A5288 strategy trial. Journal of the International AIDS Society 2022 (in press).